Introduction
Function of mature phagocytes depends on the synthesis of bactericidal and proteolytic proteins during earlier stages of phagocyte development, which are contained in primary (azurophilic) cytoplasmic granules. 1, 2 Expression patterns of primary granule proteins myeloperoxidase (MPO), proteinase-3 (also termed Myeloblastin (Mbn) or azurophil granule protein 7), neutrophil elastase (NE), cathepsin G and azurocidin (cationic protein 37) are suggestive of a common mode of regulation. [3] [4] [5] [6] [7] [8] [9] [10] Transcription and mRNA accumulation are highest at the late myeloblast/promyelocyte stage, and are downregulated in HL-60 with granulocyte-like differentiation, predominantly at the transcriptional level. [3] [4] [5] 11 Transcription factors interacting with the promoters of several of these genes are under active investigation (recently reviewed in Ref. 12 ). In addition, their DNA methylation and chromatin structure were also shown to be modulated during regulation. 9, [13] [14] [15] We examined the Mbn gene (identical to the Wegener's granulomatosis autoantigen, Refs 16 and 17) for expression and DNA methylation during myeloid development. The human Mbn gene consists of five exons and four introns 18 located on the short arm of chromosome 19, band 13.3, 19,20 at a genetic locus common with several other 'primary granule' genes. 21 The 29 kDa protein degrades extracellular matrix proteins such as collagen type IV, elastin, fibronectin, vitronectin, and laminin, 22, 23 is detectable in normal granulocytes, a fraction of monocytes, and precursor cells of phagocytes. 24, 25 At the promyelocytic stage, Mbn may play a key role for initiation of terminal differentiation. 10 Whether this is functionally linked to the often marked leukocytosis of acute phase Wegener's granulomatosis is an intriguing albeit open question. 26, 27 Studies on genes involved in the control of normal phagocyte maturation may be useful for a better understanding of disturbed maturation of leukemic myeloid cells. 28, 29 Lack of methyl residues at the 5 position of cytosine in 5Ј flanking and coding regions has been implicated in transcriptional control of developmentally regulated genes. [30] [31] [32] [33] Methylation of such sequences may play a major role in silencing of transgenes, 34, 35 of non-essential genes during in vitro culture, 36, 37 and of tumor suppressor genes in human cancers. 38, 39 In previous studies of the MPO gene, stepwise demethylation, which preceded initiation of MPO transcription, resulted in complete, stable demethylation at the myeloblast/promyelocyte stage. 9, 14, 15 In contrast, in the murine and human lysozyme genes 40, 41 and the receptor for macrophage colony-stimulating factor/c-fms, 42 highest levels of mRNA are expressed by mature phagocytes, and maximal demethylation attained in monocytes/macrophages and granulocytes. In the present study, we asked whether the kinetics of MPO gene demethylation -preceding mRNA expression, and persisting after mRNA downregulation -are similar for the Mbn gene.
Materials and methods

Cells and cell lines
HL-60 and KG-1 cells were kindly provided by H Phillip Koeffler, Cedars-Sinai Medical Center, UCLA Los Angeles, CA, USA; Kasumi-1 and NB-4 cells were from DSMZ (German Collection of Microorganisms and Cell Cultures), Braunschweig, Germany; FH-109 are normal diploid human embryonal lung fibroblasts. B-lymphoblastic TMM cells were provided by Dr Thompson, University of Galveston, TX, USA. All cell lines were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) at 37°C in a 7% CO 2 humidified atmosphere in air. For in vitro monocytic macrophage differentiation of HL-60 and KG-1, cells were cultured for 24, 48 and 72 h in the presence of 10 −7 M 12-Otetradecanoylphorbol 13-acetate (TPA, Sigma, Deisenhofen, Germany). Recombinant human (rh) granulocyte-macrophage colony-stimulating factor was kindly provided by Behringwerke, Marburg, Germany.
Heparinized venous blood or bone marrow samples were obtained from consenting donors. Light-density mononuclear cells were isolated by Ficoll-Hypaque density separation (1.077 g/l). Granulocytes (PMN) and peripheral blood mono-cytes from the blood of healthy donors were purified to Ͼ95%. 9 Peritoneal macrophages, and macrophages derived from cultured, teflon-adherent peripheral blood monocytes (kindly provided by Dr Marina Kreutz, Regensburg) were prepared and characterized as described. 43 Viability of cells was determined by trypan blue exclusion and was Ͼ90% in all experiments.
Peripheral blood progenitor cells (PBPCs) were isolated from two patients with breast cancer and a patient with nonsmall cell lung cancer following ifosfamide-based chemotherapy and administration of recombinant human G-CSF (Filgrastim; Amgen, Thousand Oaks, CA, USA) as described. 28 Mobilized PBPCs were collected by leukapheresis, CD34 + cells were positively labelled by incubation with a biotinylated IgM anti-CD34 monoclonal antibody and loaded on to an avidin-biotin immunoaffinity column (Ceprate SC system, CellPro, Bothell, WA, USA). Enriched CD34 + cells (purity: median 74%) were suspended in RPMI 1640 medium (Seromed, Germany) supplemented with glutamine (3 mmol/l) and ␤-mercaptoethanol (50 nmol/l). Aliquots of 10 6 positively selected CD34
+ cells (kindly provided by Wolfram Brugger, Tü bingen, Germany) were resuspended at 2-3 × 10 4 /ml in the presence of interleukin-(IL) 1-beta (100 ng/ml; Genzyme, Rü sselsheim, Germany), IL-3, IL-6 (both at 100 U/ml final concentration; Sandoz, Nü rnberg, Germany), stem cell factor (SCF, 100 ng/ml; Genzyme), and granulocyte colony-stimulating factor (G-CSF, 100 ng/ml; Amgen). Cells were cultured for up to 20 days and harvested at different time points. During culturing, cell numbers increased 35-to 120-fold (median: 77-fold), cell viability was Ͼ95% by trypan blue exclusion. Morphology of these cultures was scored on Wright-Giemsastained slide preparations and differential counts determined by enumeration of at least 100 cells as described. 44 
DNA probes
A 179 bp cDNA probe complementary to the 3Ј portion of exon 1, the entire exon 2, and 6 bp of exon 3 of Mbn was used for Northern and Southern hybridizations. The probe was generated by RT-PCR and subcloned as described. 11 The 405 bp SmaI/SmaI fragment of a human MPO cDNA has been previously described. 4 A full-length chicken alpha-actin cDNA 14 was used to probe for equal RNA loading and integrity of RNA.
RNA isolation and Northern blot analysis
Total cellular RNA was extracted as described.
14 Purified RNA was electrophoresed on denaturing formaldehyde-agarose gels and transferred to filter (Nytran, Schleicher and Schuell, Dassel, Germany), hybridized at 42°C (hybridization solution: 50% formamide, 5× Denhardt's solution, 0.3 M NaCl, 0.2 M PIPES, 10 mM EDTA, 1% SDS). Filters were rinsed at 37°C to a final stringency of 0.1 × SSC and autoradiographed at −70°C.
DNA blotting
DNA was isolated and purified as described. 28 For methylation analyses, DNAs were digested with a five-fold excess of HindIII, cleaved DNA was digested with either SmaI or XmaI (New England Biolabs, Beverly, MA, USA). Complete digestion was assured by adding enzyme after the first incubation.
Restricted DNAs were size-fractionated on agarose gels and transferred to nylon-based filter membrane (GeneScreen Plus, Dupont de Nemours, Wilmington, DE, USA). Hybridization with 32 P-oligolabeled probes (3-4 × 10 6 c.p.m.) was performed at 42°C. Hybridization solution contained 50% formamide, 10% dextran sulfate, 5 × Denhardt's solution, and 2 × SSPE (1 × SSPE is 0.18 M NaCl, 10 mM sodium phosphate, 1 mM EDTA). Filters were rinsed to a final stringency of 0.25 × SSC at 37°C for 15 min and exposed with Kodak X-AR 5 film (Eastman Kodak, Rochester, NY, USA) at −70°C in the presence of an intensifying screen for 1 to 6 days.
Results
Expression of proteinase-3/myeloblastin mRNA during peripheral blood progenitor differentiation
By Northern blot analysis, expression of Mbn mRNA was readily detectable in myeloid cell lines Kasumi-1, HL-60, NB-4, U937 and THP-1, as well as normal human bone marrow mononuclear cells, whereas it was undetectable in KG-1, normal peripheral blood (pb) granulocytes, pb monocytes, pb and peritoneal macrophages, phorbol ester-treated monocyte-like HL-60 cells, and several non-myeloid cells (data not shown), confirming previous studies. 10, 25, 45 Mbn expression was next examined in a differentiation model of untransformed, early hematopoietic cells. Mobilized peripheral blood progenitor cells (PBPCs) from patients with solid tumors were isolated and enriched for CD34 + cells. Cells were cultured in suspension for different time periods with two cytokine combinations which either did or did not include G-CSF. By such culture conditions, morphological differentiation along the granulocytic lineage, and expression of 'primary' granule proteins is induced. 28, 44 As shown in a representative experiment (Table 1) , a significant proportion of cells underwent granulocytic differentiation during culturing. Before culture, more than 80% of cells were of blastic and promyelocytic morphology, and cells with features of mature neutrophils were absent. At 8 days of culture, no blast-like cells were counted, less that 20% were promyelocytic cells, and more than 10% of cells had neutrophil features. With continued culturing, the proportion of cells with morphological features of mature neutrophils increased further, and was enhanced in the presence of G-CSF (Table 1) .
Mbn mRNA was not detectable in untreated PBPCs by Northern blot (Figure 1 ). In the presence of the cytokine 'cocktail' including G-CSF, expression increased to readily detectable levels within 48 to 72 h of culture, reached highest levels at 6 days (lane 8), and continuously decreased with treatment up to day 14. In the absence of G-CSF, induction of Mbn mRNA was between two-and 10-fold less. mRNA for myeloperoxidase which has a similar pattern of expression as Mbn 11 was faintly detectable in untreated cells, with maximal induction at days 6-8 with G-CSF, and days 10-14 without G-CSF, respectively (not shown).
Demethylation of Mbn gene in human phagocytes
In order to examine methylation of the 5Ј region of the Mbn gene, sequential restriction with HindIII and either SmaI (methylation-sensitive) or its isoschizomer XmaI (methylationinsensitive) was performed. Six SmaI restriction sites (labeled 'b' to 'g' in Figure 2 ) are located between the first and fourth intron of the Mbn gene. An additional SmaI site ('a') is situated 1.7 kb upstream of the transcription start site. 46 Restriction of genomic DNA from peripheral blood cells of healthy donors with HindIII and XmaI and Southern blot hybridization with the Mbn cDNA probe complementary to exon 2 resulted in a 1.7 kb fragment flanked by the SmaI/XmaI site 'b' in the first intron, and site 'c' at the 3Ј end of exon 2 ( Figure 3, lanes  5-8) . A 1.7 kb SmaI/SmaI fragment of identical size and thus indicative of complete demethylation was present in DNA from normal peripheral blood granulocytes (PMNs), monocytes, and macrophages. In both digestions, comparable hybridization signal in the low molecular weight range of Ͻ300 bp indicated restriction at sites 'c' and 'd' with both enzymes. Incubation of PMNs with GM-CSF, an activator of gene expression in neutrophils, for 24 h did not induce either Mbn expression (not shown) or a change in this restriction pattern (Figure 3 ). When analyzing granulocyte preparations from seven additional individuals (four healthy donors, one patient with leukocytosis due to septicemia, two patients with myelodysplastic syndrome (MDS), identical results were obtained (not shown).
Restriction with HindIII and SmaI of DNA from peripheral blood progenitor cells prior to in vitro differentiation resulted in a restriction fragment of 3.7 kb (Figure 4a, lane 3) . The 1.7 kb fragment was only faintly detectable, indicative Ͼ90% methylation at SmaI site 'b'. After in vitro differentiation for 14 days, the 1.7 kb restriction fragment was detectable at almost equimolar intensity as the 3.7 kb band (Figure 4a, lane 6) , indicating a decrease in methylation at site 'b' compared to cells prior to the treatment. This change was less pronounced in the absence of G-CSF (Figure 4c ). As shown in Table 1 , at day 14 the percentage of band forms and segmented neutro-
Figure 3
The Mbn gene is demethylated in granulocytes, monocytes and macrophages. DNA was purified, subjected to sequential restriction analysis with HindIII, methylation-sensitive SmaI, and with XmaI as methylation-insensitive isoschizomer control enzyme. Southern blot was hybridized to a random-primed Mbn cDNA probe. DNAs analyzed were from normal peripheral blood granulocytes (PMN, lanes 1, 5, 9); PMNs incubated in the presence of recombinant human GM-CSF (50 ng/ml for 24 h, lanes 2, 6, 10), normal peripheral blood monocytes (lanes 3, 7, 11) and monocytes cultured by adherence to teflon for 8 days (lanes 4, 8, 12 ).
phil-like cells was 47% (with G-CSF) and 26% (without G-CSF), respectively. In constrast, hybridization with an MPO cDNA resulted in an identical restriction fragment of 3.3 kb in both the HindIII/SmaI and HindIII/XmaI digestions and irrespective of in vitro differentiation (Figure 4b, d) . We have previously mapped this fragment to a demethylated CpG site that is part of a CpG island within the MPO gene. 9, 14 Demethylation of this island is present in myeloblastic and promyelocytic leukemias which express MPO mRNA. 14 Analysis of the Mbn methylation status was extended to several myeloid and non-myeloid cells and cells lines (Figure 5a,  b) . The 3.7 kb restriction fragment was detected in HL-60, Kasumi-1, NB-4 and peripheral blood lymphocytes. Surprisingly, it was also seen in embryonal lung fibroblasts FH-109. A 4.1 kb band indicative of partial methylation at SmaI site 'a' was observed in HL-60, KG-1, in normal human bone marrow cells (NHBM) and FH-109. A heterozygous restriction length polymorphism causing this duplex band appears highly unlikely considering the variable band ratio in several cell types, and identical restriction patterns after digestion with XmaI. The restriction pattern of NHBM, with predominance of 1.7 kb fragment, may be best explained by its cellular heterogeneity. Semiquantitative methylation patterns as derived from these experiments are plotted in Figure 5b . Hybridization of DNA from Kasumi-1 and NB-4 cells, which showed partial methylation at SmaI site 'b', with an MPO cDNA revealed the 3.3 kb fragment indicative of complete demethylation at both SmaI sites flanking this fragment (Figure 5c ).
Discussion
Common modes of regulation probably underlie the coordinate expression of the 'primary granule' proteins of phagocytic blood cells and their precursors. 2, 47 Expression occurs within a narrow 'window' of maturation (late myeloblastic/ promyelocytic), and transcriptional down-regulation during further differentiation. 2 Modes of down-regulation of the MPO gene during induction of granulocytic and monocytic differentiation of HL-60 cells were determined using nuclear run-off and mRNA half-life experiments. 3, 4 These studies showed that shut-off of the MPO gene occurs predominantly at the transcriptional level; kinetics of the decreased rate of MPO transcription during monocyte-like differentiation of HL-60 cells by phorbol ester were consistent with an 'immediate-early gene' response, 11 and were almost identical for Mbn, as shown by several laboratories. 6, 11 MPO and Mbn gene 5Ј noncoding regions share a cytidine-rich element which in Mbn is in close spatial and probably functional proximity to a PU.1 binding site. The trans-acting factor binding the cytidine-rich sequence has not yet been identified. 48 In the present study, normal peripheral blood progenitor cells (PBPCs) enriched for CD34-positive cells which provide an abundant source of homogenous, untransformed hemopoietic progenitor cells, were used to study expression and methylation of Mbn. By this in vitro model of cytokineinduced phagocyte differentiation, the untreated, CD34-positive cells did not express Mbn which, however, was markedly upregulated during culturing. This effect was enhanced more than 10-fold by G-CSF. The kinetics of Mbn expression in this model bear strong resemblance to those of MPO. 28 Several studies by others as well as ourselves have demonstrated that stepwise cytosine demethylation is linked to myeloid differentiation. 9, 14, 15, [40] [41] [42] Thus, demethylation of the MPO gene (heavily methylated in early myeloid cells and non-myeloid cells) accompanies the maturational steps up to the late myeloblast/promyelocyte stage, where the MPO gene is completely demethylated at several CpG sites, and no further changes of this pattern occur during terminal maturation. 9, 14 We reasoned that the similar modes of regulation of MPO and Mbn expression warranted examination of Mbn gene methylation patterns. These were quite distinct in different cell types. In mature normal granulocytes and monocytes, a 1.7 kb restriction fragment indicative of complete demethylation was consistently detected. Normal CD34 + enriched PBPCs representing immature, untransformed hematopoietic cells revealed a pattern of almost complete methylation of a SmaI site in Mbn intron 1 which, however, underwent partial demethylation with in vitro differentiation. The Southern blot technique is limited by semiquantitative detection of only selected CpG nucleotides. PCR assays using bisulfite-modified DNA would provide a quantitative and sensitive approach to capture such changes. 38, 39 Results from methylation studies during myelopoiesis suggest the following sequence: the CD34 gene (marker of very immature hematopoietic progenitor cells) is completely demethylated at early stages of lineage commitment, and this pattern is unchanged throughout maturation. 28 The receptor for macrophage colony-stimulating factor/c-fms (highly expressed by terminally differentiated macrophages, absent in granulocytes), shows a strong correlation with demethylation within the second exon of c-fms. 42 The lysozyme gene (highly expressed by terminally differentiated macrophages, monocytes and granulocytes), is completely demethylated in these cells. 40, 41 MPO (highest expression at late myeloblast/ promyelocyte stage) becomes completely demethylated at that stage, a pattern that remains stable during terminal differentiation. In the present study, we show that the Mbn gene attains complete demethylation of several SmaI sites at a later differentiation stage than MPO at selected restriction sites, with incomplete demethylation in myeloblasts and promyelocytes in the Mbn gene but not the MPO gene. 9, 14 The possible role(s) of the differentially methylated sequences within these genes are as yet unclear. Localization of differentially methylated sites close to or within the CD34 and MPO promoter regions suggests a possible role in transcriptional control, and in the human LZM gene, differentially methylated sites are located within four Alu repetitive elements, two of which also map near the putative promoter region. 41 In summary, a differentiation-associated pattern of demethylation occurs in the Mbn gene during maturation of phagocytic cells, providing a molecular marker for developmental stages of myeloid cells, and for monitoring during treatment of MDS with DNA methylation inhibitors. [49] [50] [51] Transcriptional inactivation associated with densely methylated promoters is mediated at least in part by binding of MeCP2, a ubiquitously expressed protein binding to methylcytosine but not cytosine. The ability of MeCP2 to recruit histone deacetylase and a corepressor complex may explain the association of hypermethylated DNA with closed, inactive chromatin. 52, 53 Recently, a mammalian mCpG-binding protein with demethylase activity has been identified by Szyf and coworkers. 54 Considering the progressive demethylation of several myeloid-specific genes during phagocyte maturation, it is tempting to speculate that this demethylating protein may be upregulated during myeloid differentiation. Finally, the tissue-and development-specific trans-acting factors interacting with differentially methylated sequences during myelopoiesis remain to be identified. Whether methylation changes in these tissue-specific genes are permissive for differentiation or a bystander phenomenon should be further clarified by such studies.
